• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMylan

Mylan

Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
Magazine
Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
By Geoff ColvinDecember 6, 2021
The drug giant will merge its off-patent unit with generic drug company Mylan.
Health
Generic Drug Industry Sees New Giant as Pfizer Merges Off-Patent Unit With Mylan
By Timothy Annett, Riley Ray Griffin and BloombergJuly 29, 2019
EpiPen shortage Walgreens Auvi-Q
Health
There’s Still a Big EpiPen Shortage—But Walgreens Will Start Selling a Competing Product
By Sy MukherjeeSeptember 7, 2018
FDA EpiPen generic
Health
The FDA Finally Approved an EpiPen Generic. But a Shortage Looms Ahead of the School Year
By Sy MukherjeeAugust 16, 2018
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Health
Mylan Is Surging and Teva Is Slumping After the FDA Okayed This New Drug
By ReutersOctober 4, 2017
Protestors Rally In New York Against EipPen Price Gouging Scandal
Retail
Investors Are Calling on Mylan’s Chairman and Director to Step Down
By ReutersJune 28, 2017
House Oversight Committee Holds Hearing On Rising Price Of EpiPens With Mylan Inc. CEO Heather Bresch
Health
EpiPen Maker Mylan Saves Millions in Taxes Thanks to Huge Stakes in Coal Companies
By Sy MukherjeeJune 21, 2017
Mylan NV EpiPen 2-Pak medication sits on a table inside a pharmacy in Provo, Utah, U.S., on Wednesday, Aug. 31, 2016.
Health
Will the Newest EpiPen Competitor Steal Even More Market Share from Mylan?
By Sy MukherjeeJune 19, 2017
Pharmaceutical Drug Roundup Inside A Pharmacy
Health
Mylan Shareholders Are Being Advised to Vote Against Board Members and Executive Pay Packages
By ReutersJune 12, 2017
Robert J. Coury, vice chairman and chief executive officer o
Health
Mylan’s Shareholders Fight to Dump Its Board After the Epipen Scandal
By ReutersMay 31, 2017
Global Pharmaceuticals Brands
Finance
Mylan’s EpiPen Recall Couldn’t Come at a Worse Time
By Jen WiecznerApril 3, 2017
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
Health
Mylan’s Massive Recall of Faulty EpiPens Spreads to the U.S.
By Aric JenkinsApril 1, 2017
FDA Rejects Mylan’s Copycat of GSK’s Asthma Drug
Health
FDA Rejects Mylan’s Copycat of GSK’s Asthma Drug
By Sy MukherjeeMarch 29, 2017
Mylan NVs EpiPen Product Illustrations As Company's Move to Curb EpiPen Costs Blasted as PR Fix by Congress
Health
Mylan Recalls 81,000 EpiPens Outside U.S. After Reports of Failure
By ReutersMarch 23, 2017
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
Health
Mylan’s EpiPen Is Bleeding Market Share to Its Rivals
By Sy MukherjeeMarch 6, 2017
1
  • 1
  • 2
  • 3
  • 4
  • 5
6
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Newsletters
The Supreme Court's birthright citizenship ruling hands the U.S. economy a $7.7 trillion winplaceholder alt text
By Diane BradyJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.